NTRC Competitors and Similar CompaniesClear all
NTRC's competitors and similar companies include Nektar Therapeutics and Candel Therapeutics.
 NTRC NTRC (Netherlands Translational Research Center) is a precision medicine biotech company dedicated to the development of anti-cancer drugs. |  Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ||
Founding Date | Founding Date 2011 | Founding Date 1990 | Founding Date 1999 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Oss, NL HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Needham, US HQ |
Employees | Employees 2 | Employees 61821% increase | Employees 50 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.8 m | Valuation ($) 176.8 m |
Financial | |||
Net income | Net income N/A | Net income ($164.1m) (FY, 2025) | Net income ($38.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 60.7k | Total funding raised $ 45m | Total funding raised $ 64.6m |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyCandel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View company